Microbix Biosystems Inc.
MBXBF
$0.16
$0.013.45%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.32% | -32.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.32% | -32.36% | |||
| Cost of Revenue | 8.74% | -1.04% | |||
| Gross Profit | 7.73% | -53.68% | |||
| SG&A Expenses | 7.21% | -9.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.77% | -3.21% | |||
| Operating Income | -6.30% | -871.89% | |||
| Income Before Tax | 6.05% | -8,345.14% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.46% | -8,345.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.46% | -8,345.14% | |||
| EBIT | -6.30% | -871.89% | |||
| EBITDA | -17.59% | -251.29% | |||
| EPS Basic | 5.95% | -8,500.00% | |||
| Normalized Basic EPS | 3.77% | -5,400.00% | |||
| EPS Diluted | 6.90% | -8,800.00% | |||
| Normalized Diluted EPS | 3.77% | -5,400.00% | |||
| Average Basic Shares Outstanding | -3.10% | 0.52% | |||
| Average Diluted Shares Outstanding | -3.12% | -0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||